ULK1 Depletion Protects Mice from Diethylnitrosamine-Induced Hepatocarcinogenesis by Promoting Apoptosis and Inhibiting Autophagy

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(Suppl 1):4–13. doi:10.1002/hep.31288
   PubMed Web of Science ®Google Scholar
• Raffetti E, Portolani N, Molfino S, et al. Is survival for hepatocellular carcinoma increasing? A population-based study on survival of hepatocellular carcinoma patients in the 1990s and 2000s. Clin Res Hepatol Gastroenterol. 2021;45(1):101433. doi:10.1016/j.clinre.2020.04.004
   PubMed Web of Science ®Google Scholar
• Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Chapter One - Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. In: Sarkar D, Fisher PB editors. Advances in Cancer Research. Vol 149. Mechanisms and Therapy of Liver Cancer. Academic Press; 2021:1–61. doi:10.1016/bs.acr.2020.10.001
   Google Scholar
• Llovet JM, Pinyol R, Kelley RK, et al. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nat Cancer. 2022;3(4):386–401. doi:10.1038/s43018-022-00357-2
   PubMedGoogle Scholar
• Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2006;17(1):1–382. doi:10.1080/15548627.2020.1797280
   Google Scholar
• Mathea S, Salah E, Tallant C, et al. Conformational plasticity of the ULK3 kinase domain. Biolchem J. 2021;478(14):2811–2823. doi:10.1042/BCJ20210257
   Google Scholar
• Zachari M, Ganley IG. The mammalian ULK1 complex and autophagy initiation. Essays Biochem. 2017;61(6):585–596. doi:10.1042/EBC20170021
   PubMed Web of Science ®Google Scholar
• Demeter A, Romero-Mulero MC, Csabai L, et al. ULK1 and ULK2 are less redundant than previously thought: computational analysis uncovers distinct regulation and functions of these autophagy induction proteins. Sci Rep. 2020;10(1):10940. doi:10.1038/s41598-020-67780-2
   PubMed Web of Science ®Google Scholar
• Li TY, Sun Y, Liang Y, et al. ULK1/2 constitute a bifurcate node controlling glucose metabolic fluxes in addition to autophagy. Mol Cell. 2016;62(3):359–370. doi:10.1016/j.molcel.2016.04.009
   PubMed Web of Science ®Google Scholar
• Joshi A, Iyengar R, Joo JH, et al. Nuclear ULK1 promotes cell death in response to oxidative stress through PARP1. Cell Death Differ. 2016;23(2):216–230. doi:10.1038/cdd.2015.88
   PubMed Web of Science ®Google Scholar
• Zhang L, Fu L, Zhang S, et al. Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo. Chem Sci. 2017;8(4):2687. doi:10.1039/c6sc05368h
   PubMed Web of Science ®Google Scholar
• Mao L, Zhan Y, Wu B, et al. ULK1 phosphorylates Exo70 to suppress breast cancer metastasis. Nat Commun. 2020;11(1):117. doi:10.1038/s41467-019-13923-7
   PubMed Web of Science ®Google Scholar
• Tang F, Hu P, Yang Z, et al. SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways. Oncol Rep. 2017;37(6):3449–3458. doi:10.3892/or.2017.5635
   PubMed Web of Science ®Google Scholar
• Liu J, Long S, Wang H, et al. Blocking AMPK/ULK1-dependent autophagy promoted apoptosis and suppressed colon cancer growth. Cancer Cell Int. 2019;19:336. doi:10.1186/s12935-019-1054-0
   PubMed Web of Science ®Google Scholar
• Singha B, Laski J, Ramos Valdés Y, et al. Inhibiting ULK1 kinase decreases autophagy and cell viability in high-grade serous ovarian cancer spheroids. Am J Cancer Res. 2020;10(5):1384–1399.
   PubMed Web of Science ®Google Scholar
• Xue S-T, Li K, Gao Y, et al. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target. Autophagy. 2020;16:1823–1837. doi:10.1080/15548627.2019.1709762
   PubMed Web of Science ®Google Scholar
• Xu H, Yu H, Zhang X, et al. UNC51-like kinase 1 as a potential prognostic biomarker for hepatocellular carcinoma. Int J Clin Exp Pathol. 2013;6(4):711–717.
   PubMed Web of Science ®Google Scholar
• Kundu M, Lindsten T, Yang CY, et al. Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation. Blood. 2008;112(4):1493–1502. doi:10.1182/blood-2008-02-137398
   PubMed Web of Science ®Google Scholar
• Mohr U, ed. International Classification of Rodent Tumors. 1st ed. Springer; 2001.
   Google Scholar
• Franken NAP, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1(5):2315–2319. doi:10.1038/nprot.2006.339
   PubMed Web of Science ®Google Scholar
• Duan T, Sun W, Zhang M, et al. Dietary restriction protects against diethylnitrosamine-induced hepatocellular tumorigenesis by restoring the disturbed gene expression profile. Sci Rep. 2017;7:43745. doi:10.1038/srep43745
   PubMed Web of Science ®Google Scholar
• Wu D, Wang TT, Ruan DY, et al. Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma. Biomed Pharmacother. 2018;97:195–202. doi:10.1016/j.biopha.2017.10.025
   PubMed Web of Science ®Google Scholar
• Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31–46. doi:10.1158/2159-8290.CD-21-1059
   PubMed Web of Science ®Google Scholar
• Cozzo AJ, Coleman MF, Pearce JB, et al. Dietary energy modulation and autophagy: exploiting metabolic vulnerabilities to starve cancer. Front Cell Dev Biol. 2020;8:590192. doi:10.3389/fcell.2020.590192
   PubMed Web of Science ®Google Scholar
• Chavez-Dominguez R, Perez-Medina M, Lopez-Gonzalez JS, et al. The double-edge sword of autophagy in cancer: from tumor suppression to pro-tumor activity. Front Oncol. 2020;10:578418. doi:10.3389/fonc.2020.578418
   PubMed Web of Science ®Google Scholar
• Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 2003;112(12):1809–1820. doi:10.1172/JCI20039
   PubMed Web of Science ®Google Scholar
• Strohecker AM, Guo JY, Karsli-Uzunbas G, et al. Autophagy sustains mitochondrial glutamine metabolism and growth of braf V600E–driven lung tumors. Cancer Discov. 2013;3(11):1272–1285. doi:10.1158/2159-8290.CD-13-0397
   PubMed Web of Science ®Google Scholar
• Deng J, Thennavan A, Dolgalev I, et al. ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer. Nat Cancer. 2021;2(5):503–514. doi:10.1038/s43018-021-00208-6
   PubMedGoogle Scholar
• Qiu X, Zheng L, Liu X, et al. ULK1 inhibition as a targeted therapeutic strategy for psoriasis by regulating keratinocytes and their crosstalk with neutrophils. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.714274
   Web of Science ®Google Scholar
• Saleiro D, Mehrotra S, Kroczynska B, et al. Central Role of ULK1 in Type I Interferon Signaling. Cell Rep. 2015;11(4):605–617. doi:10.1016/j.celrep.2015.03.056
   PubMed Web of Science ®Google Scholar
• Saleiro D, Blyth GT, Kosciuczuk EM, et al. IFNγ-inducible antiviral responses require ULK1-mediated activation of MLK3 and ERK5. Sci Signal. 2018;11:eaap9921. doi:10.1126/scisignal.aap9921
   PubMed Web of Science ®Google Scholar
• Vidal P . Interferon α in cancer immunoediting: From elimination to escape. Scandinavian Journal of Immunology. 2020;91(5):e12863. doi:10.1111/sji.12863
   Web of Science ®Google Scholar
• Tong S, Cinelli MA, El-Sayed NS, et al. Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS). Sci Rep. 2022;12. doi:10.1038/s41598-022-05394-6
   Web of Science ®Google Scholar
• Zhuang X, Shi G, Hu X, et al. Interferon-gamma inhibits aldehyde dehydrogenase bright cancer stem cells in the 4T1 mouse model of breast cancer. Chin Med J. 2022;135:194–204. doi:10.1097/CM9.0000000000001558
   Web of Science ®Google Scholar
• Jones DM, Read KA, Oestreich KJ. Dynamic roles for IL-2-STAT5 signaling in effector and regulatory CD4+ T cell populations. J Immunol. 2020;205(7):1721–1730. doi:10.4049/jimmunol.2000612
   PubMed Web of Science ®Google Scholar
• Halim CE, Deng S, Ong MS, et al. Involvement of STAT5 in Oncogenesis. Biomedicines. 2020;8:316. doi:10.3390/biomedicines8090316
   PubMed Web of Science ®Google Scholar
• Erickson S, Matikainen S, Thyrell L, et al. Interferon-alpha inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes. European J Biochem. 2002;269(1):29–37. doi:10.1046/j.0014-2956.2002.02626.x
   PubMedGoogle Scholar